Brief: Cluny Capital Announces Additional Details Of Its Qualifying Transaction With Teonan Biomedical
Nov 30 (Reuters) - Cluny Capital Corp CLNh.V :
* CLUNY CAPITAL ANNOUNCES ADDITIONAL DETAILS OF ITS
QUALIFYING
TRANSACTION WITH TEONAN BIOMEDICAL INC.
* TEONAN WILL AMALGAMATE WITH A WHOLLY-OWNED SUBSIDIARY OF
COMPANY
IN ORDER TO FACILITATE COMPLETION OF PROPOSED TRANSACTION
* WILL CONTINUE TO CARRY ON BUSINESS OF TEONAN AND WILL BE
LISTED
AS A TIER 2 LIFE SCIENCES ISSUER ON EXCHANGE
Source text for Eikon: ID:nGNX5cg6Qh
Further company coverage: CLNh.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mercanto Holdings
See all newsBrief: Mercanto Holdings Reports Strong Early Performance Of New Québec Listings And Steady Core Portfolio
Brief: Mercanto Reports Q3 2025 Financial Results And Provides Operational Update
Brief: The Good Shroom Co Reports Year End Financial Results
Brief: The Good Shroom Provides An Update On It's Expansion Activities.
Brief: Good Shroom Posts Q1 Revenue Of C$822,569